Sen-Jam 02-06-2026 News & Company Updates The Biggest Problem in Modern Medicine: Inflammation Read More
Sen-Jam 06-11-2025 News & Company Updates Sen-Jam Pharmaceutical Takes the Stage at European Biopharma Obesity Innovation Forum Read More
Sen-Jam 04-16-2025 Longevity & Healthspan The End of Sickcare: From the Inside Out: A Spotlight on Cellular Longevity at the Global Passion Project Summit Read More
Sen-Jam 03-27-2025 News & Company Updates Behind the Breakthrough: Strategic Insights from Sen-Jam's Executive Leadership and Destum Partners Read More
Sen-Jam 03-23-2025 News & Company Updates Patent Milestone and Stability Data Strengthen Licensing Value of SJP-002C Read More
Sen-Jam 03-11-2025 News & Company Updates Sen-Jam Pharmaceutical Welcomes Immunology and Infectious Disease Expert Dr. Ashley St. John to its Scientific Advisory Board Read More
Sen-Jam 02-10-2025 News & Company Updates Sen-Jam Pharmaceutical Engages Destum Partners to Source Strategic Partnerships for SJP-001 & SJP-002C Read More
Sen-Jam 01-25-2025 News & Company Updates Sen-Jam Pharmaceutical Answers Surgeon General's Alarm with a New Therapeutic Aimed at Tackling Alcohol Related Risks Read More
Sen-Jam 01-15-2025 News & Company Updates Sen-Jam Pharmaceutical Announces Preliminary Results from Phase 2 Clinical Trials of SJP-002C for Upper Respiratory Infections/COVID-19 Read More
Sen-Jam 01-14-2025 News & Company Updates Sen-Jam Pharmaceutical: Revolutionizing Inflammatory Care with Proprietary PAIR Technology for Metabolic Balance and Inflammation Resolution Read More
Sen-Jam 01-10-2025 News & Company Updates Sen-Jam Pharmaceutical Announces Planned AI Initiative for Repurposed Drug Development Read More
Sen-Jam 01-10-2025 New Global Scientific Paper Published on Alcohol Hangover, Inflammation, and Health Read More
Sen-Jam 01-09-2025 News & Company Updates Sen-Jam Pharmaceutical Files Groundbreaking Patent for Novel Therapeutic Approach to Address Obesity and Metabolic Disorders Read More
